Lymphoma, Large B-Cell, DiffuseLymphoma, B-CellLymphomaLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, T-CellLymphoma, B-Cell, Marginal ZoneGerminal CenterB-LymphocytesProto-Oncogene Proteins c-bcl-6Lymphoma, T-Cell, PeripheralLymphoma, Large-Cell, ImmunoblasticVincristineAntibodies, Monoclonal, Murine-DerivedBurkitt LymphomaAntigens, CD79PrognosisAntigens, CD20Mediastinal NeoplasmsPrednisoneMyelin and Lymphocyte-Associated Proteolipid ProteinsImmunohistochemistryHodgkin DiseaseEpstein-Barr Virus InfectionsAntigens, CD40CD40 LigandAntigens, CD8ImmunophenotypingTumor Markers, BiologicalTranslocation, GeneticAntigens, CD3CyclophosphamideDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Mantle-CellTreatment OutcomeLymphoproliferative DisordersRetrospective StudiesAntigens, CD44Immunoglobulin Heavy ChainsLymphoma, T-Cell, CutaneousFatal OutcomeAntigens, CD34CARD Signaling Adaptor ProteinsB-Lymphocyte SubsetsAntigens, CD28Lymphoma, AIDS-RelatedSurvival AnalysisChemotherapy-Induced Febrile NeutropeniaCD4-CD8 RatioHerpesvirus 4, HumanLymphoma, Large-Cell, AnaplasticAntigens, CD5Antigens, CDAntigens, CD19Gene Expression Regulation, NeoplasticCell Line, TumorAntigens, CD38CD4-Positive T-LymphocytesAntigens, CD30Gene Expression ProfilingSurvival RateProto-Oncogene Proteins c-bcl-2Remission InductionNeoplasm StagingAntigens, CD14Polymerase Chain ReactionAntigens, CD80Disease-Free SurvivalAntigens, CD95DNA-Binding ProteinsFlow CytometryAntigens, CD1Lymphocyte ActivationAntigens, CD2Lymph NodesSpleenAntigens, CD56MutationPredictive Value of TestsFollow-Up StudiesKaplan-Meier EstimateImmunoglobulin MMultivariate AnalysisAntigens, CD86Antibodies, MonoclonalLeukemia, Lymphocytic, Chronic, B-CellAntigens, CD24Antigens, CD18Proportional Hazards ModelsCD8-Positive T-LymphocytesTime FactorsAntigens, CD7Mice, TransgenicImmunoglobulin DGenes, ImmunoglobulinMice, Inbred C57BLAntigens, CD9Gene Rearrangement, B-LymphocyteAntigens, CD70